- Outdated 1960s liposomal technology
- Less than 1% reaches the cells
- High doses needed to compensate
- Eroding consumer trust
<1%Bioavailability
Branded ingredients · Verdant Nature
BioSNEDS™ — the future of nutraceuticals.
A self-emulsifying delivery technology that turns a trickle of benefit into a flood of vitality — boosting the bioavailability of active ingredients by up to 10,000%, at lower doses.
The bioavailability crisis
Most supplements deliver less than 1%.
Consumers pay top dollar for supplements that promise the world, yet many deliver under 1% of their active ingredients to human cells — and the market still leans on outdated 1960s liposomal technology.
BioSNEDS™ is a paradigm shift: advanced self-emulsifying delivery that makes actives bioaccessible, cold-water soluble and ready to be absorbed where they're needed most.
See the ingredient portfolio
<1%Standard nutraceuticals
10,000%Up to — BioSNEDS™
4Target industries
The difference is clear
From a trickle to a flood of vitality.
Same active ingredient, a fundamentally different outcome — because delivery, not dose, decides how much actually reaches your cells.
- Advanced self-emulsifying delivery
- Bioaccessible & cold-water soluble
- Potent results at lower doses
- Earns and keeps consumer trust
10,000%Up to — bioavailability
The BioSNEDS™ advantage
Precision delivery for maximum cellular impact.
Cutting-edge science meets nature's wisdom — four mechanisms that work together to get actives into your cells.
Double Bubble design
Dual-layer protection and targeted delivery, letting nutrients be absorbed exactly where they're most needed.
“Trojan Horse” mechanism
Shields active ingredients through the digestive tract and releases them predictably at the absorption sites.
Liver-bypass brilliance
Rides the lymphatic system like dietary fat, circumventing first-pass liver metabolism for optimal absorption.
Cellular-uptake mastery
Fuses with cell membranes for efficient, direct nutrient transfer at the cellular level.
Optimised pharmacokinetics
Prolonged, targeted, cellular release.
A biphasic “two-compartment” model and ultradeformable vesicles deliver actives steadily — then place them precisely inside the cell.
Lymphatic uptake
Absorbed via the lymphatic system, avoiding first-pass liver metabolism.
Extended plasma half-life
Actives stay in circulation longer for sustained, prolonged therapeutic effect.
Membrane fusion & trafficking
SNAP/SNARE-mediated fusion transfers actives directly into the cell, mimicking natural biological processes.
Versatile by design
Three delivery systems. Four industries.
Three targeted delivery systems
01CellsDirect cellular uptake
02Blood-brain barrierTargeted CNS delivery
03MitochondriaComing soon
Four high-growth industries
Dietary supplements
Functional food & beverage
Cosmeceuticals
Pet wellness
The portfolio
20+ high-bioavailability nutraceuticals.
Every BioSNEDS™ ingredient dramatically out-delivers its conventional form — with new additions every quarter.
10,000%EllagiSol™
4,440%NADPro™
4,330%ResveraSol™
4,020%CurcuSol™
3,040%BioButyrin™
3,030%OmegaXorb EPA™
| Conventional ingredient | Bioavailability | BioSNEDS™ ingredient | Increased |
|---|---|---|---|
| Apigenin | ≈1% | ApigenSol™ | 2,500% |
| Astaxanthin | ≈10% | AstaXorb™ | 1,990% |
| Berberine | ≈0.68% | BerberiSol™ | 1,490% |
| Tributyrin | ≈21% | BioButyrin™ | 3,040% |
| β-Caryophyllene | ≤6% | BCPro™ | 3,000% |
| CoQ10 | ≈1% | CoQXorb™ | 2,500% |
| Creatine monohydrate | ≈17% | CreaXorb™ | 2,200% |
| Curcumin | ≤1% | CurcuSol™ | 4,020% |
| Ellagic acid | ≈0.2% | EllagiSol™ | 10,000% |
| HMB | ≈44% | HMBPro™ | 2,200% |
| Hyaluronic acid | ≈0.2% | HyaluronX | 1,483% |
| Melatonin | ≈3% | MelaXorb™ | 2,000% |
| Quercetin + niacinamide | ≈1% | NADPro™ | 4,440% |
| Omega DHA | ≈15% | OmegaXorb DHA™ | 1,570% |
| Omega EPA | ≈10% | OmegaXorb EPA™ | 3,030% |
| Piperine | ≤3% | PiperiSol™ | 3,000% |
| Quercetin | ≈1% | QuerceSol™ | 1,530% |
| Resveratrol | ≤1% | ResveraSol™ | 4,330% |
| Tetrahydrocurcumin | ≤5% | TCurcuSol™ | 2,000% |
| Theobromine | ≈40% | TeBromiSol™ | 2,020% |
| Thymoquinone | ≈1% | ThymoPro™ | 1,390% |
Bioavailability figures based on PK and PAMPA results; increases vary by specific formulation (an oral delivery comparison).
Surpassing the competition
Beyond micronization and liposomes.
Compared category by category against the alternatives, BioSNEDS™ isn't just competing — it's defining a new standard.
| Feature | BioSNEDS™ | Micronization | Liposomal |
|---|---|---|---|
| Bioavailability boost | up to 10,000% | avg 200% | avg 200–1,000% |
| GI protection | Superior | Minimal | Moderate |
| Lymphatic uptake | Superior | Minimal | Minimal |
| Bypass first-pass liver | Yes | No | No |
| Plasma half-life | Extended | Short | Variable |
| Stability | Superior | Limited | Variable |
| Plasma release | Controlled | Rapid | Inconsistent |
| Intracellular delivery | Facilitated | Limited | Inconsistent |
| Particle size | Ultra-fine | Fine | Small |
| Versatility | Excellent | Limited | Good |
Clinically proven
Validated, not just promised.
BioSNEDS™ isn't theory — the self-emulsifying technology has been validated through rigorous scientific studies, clinical trials and research partnerships confirming dramatically enhanced bioavailability and absorption.
BioSNEDS™ partners program
Accelerate your success.
More than a technology — a dedicated ally committed to your brand's long-term growth. When you adopt BioSNEDS™, you gain a full partnership toolkit.
- Co-brandable marketing assets
- Cutting-edge scientific resources
- Sales empowerment tools
- Event co-exhibiting opportunities
- Dedicated marketing support
- Influencer collaboration access
Your future starts here
Are you ready to make history?
Join us as partners, pioneers and architects of a healthier world — and put BioSNEDS™ high-bioavailability ingredients behind your brand.